Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus.

Goto H, Wells K, Takada A, Kawaoka Y.

J Virol. 2001 Oct;75(19):9297-301.

2.
3.

Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus.

Li S, Schulman J, Itamura S, Palese P.

J Virol. 1993 Nov;67(11):6667-73.

4.

Assays for functional binding of plasminogen to viral proteins.

Goto H, Kawaoka Y.

Methods. 2000 Jun;21(2):159-63.

PMID:
10816377
5.
6.

Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication.

Suzuki T, Takahashi T, Guo CT, Hidari KI, Miyamoto D, Goto H, Kawaoka Y, Suzuki Y.

J Virol. 2005 Sep;79(18):11705-15.

7.

A new approach to an influenza live vaccine: modification of the cleavage site of hemagglutinin.

Stech J, Garn H, Wegmann M, Wagner R, Klenk HD.

Nat Med. 2005 Jun;11(6):683-9. Epub 2005 May 29.

PMID:
15924146
8.

Influenza A viruses lacking sialidase activity can undergo multiple cycles of replication in cell culture, eggs, or mice.

Hughes MT, Matrosovich M, Rodgers ME, McGregor M, Kawaoka Y.

J Virol. 2000 Jun;74(11):5206-12.

9.
10.

Alterations in caspase cleavage motifs of NP and M2 proteins attenuate virulence of a highly pathogenic avian influenza virus.

Zhirnov OP, Klenk HD.

Virology. 2009 Nov 10;394(1):57-63. doi: 10.1016/j.virol.2009.08.013. Epub 2009 Sep 10.

11.
12.

Plasminogen promotes influenza A virus replication through an annexin 2-dependent pathway in the absence of neuraminidase.

LeBouder F, Lina B, Rimmelzwaan GF, Riteau B.

J Gen Virol. 2010 Nov;91(Pt 11):2753-61. doi: 10.1099/vir.0.023804-0. Epub 2010 Aug 11.

PMID:
20702651
14.

A new approach to an influenza life vaccine: haemagglutinin cleavage site mutants generated by reverse genetics.

Stech J, Klenk HD.

Berl Munch Tierarztl Wochenschr. 2006 Mar-Apr;119(3-4):186-91. Review.

PMID:
16573209
15.

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

Ives JA, Carr JA, Mendel DB, Tai CY, Lambkin R, Kelly L, Oxford JS, Hayden FG, Roberts NA.

Antiviral Res. 2002 Aug;55(2):307-17.

PMID:
12103431
16.

The virulence of the 1918 pandemic influenza virus: unraveling the enigma.

Taubenberger JK.

Arch Virol Suppl. 2005;(19):101-15.

PMID:
16355870
18.
19.

Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus.

Kobasa D, Takada A, Shinya K, Hatta M, Halfmann P, Theriault S, Suzuki H, Nishimura H, Mitamura K, Sugaya N, Usui T, Murata T, Maeda Y, Watanabe S, Suresh M, Suzuki T, Suzuki Y, Feldmann H, Kawaoka Y.

Nature. 2004 Oct 7;431(7009):703-7.

PMID:
15470432
20.

A novel mechanism for the acquisition of virulence by a human influenza A virus.

Goto H, Kawaoka Y.

Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):10224-8.

Supplemental Content

Support Center